While different positions on the permissibility of organ markets enjoy support, there is widespread agreement that some benefits to living organ donors are acceptable and do not raise the same moral concerns associated with organ markets, such as exploitation and commodification. We argue on the basis of two distinctions that some benefit packages offered to donors can defensibly surpass conventional reimbursement while stopping short of controversial cash payouts. The first distinction is between benefits that defray the costs of donating an organ and benefits that incentivize donation by offering something in excess of defraying. The second distinction is between benefits that compensate donors and benefits that are non-compensating. We argue that non-compensating benefits are innocent of moral concerns typically associated with controversial cash payouts, and thus may be a morally promising avenue for increasing rates of kidney donation to address the tragic results of undersupply.

虽然关于器官市场允许性的不同立场得到支持，但人们普遍认为活体器官捐赠者的一些好处是可以接受的，并且不会引起与器官市场相关的道德问题，例如剥削和商品化。我们基于两个区别认为，提供给捐助者的一些福利计划可以合理地超越传统的报销，同时阻止有争议的现金支付。第一个区别是 支付 器官捐赠成本的福利和通过提供超出支出的东西来激励捐赠的福利。第二个区别是 补偿 捐助者的福利和非补偿的福利 。 我们认为，非补偿性福利与通常与有争议的现金支出相关的道德问题无关，因此可能是提高肾脏捐赠率以解决供应不足的悲惨后果的一个道德上有希望的途径。